Search the Newsreel

Mirion Technologies (MIR) Nuclear Growth Story Meets Questions Over Fair Value

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Mirion Technologies (MIR) has drawn fresh attention after recent trading left the stock at $16.88. Returns over the past month and past 3 months both …

MIRA Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:MIRA)

This article provides an overview of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) financial actuals and estimates as presented on TradingView. It covers past stock performance, analyst forecasts, historical high and low prices, market capitalization, and upcoming earnings dates. The content also addresses frequently asked questions about …

How Investors Are Reacting To Mirion Technologies (MIR) Analysts Turning More Optimistic On Earnings Estimates

Mirion Technologies (MIR) analysts have shown increased optimism regarding the company's earnings outlook ahead of its June 2026 quarter results, with the Most Accurate Estimate now exceeding the broader Zacks Consensus Estimate. This shift suggests a positive re-evaluation of Mirion's investment narrative, which is …

Enterprise value to EBIT forward of Scotts Miracle-Gro Company Class A – LSE:0L45

This article displays the enterprise value to EBIT forward for Scotts Miracle-Gro Company Class A (LSE:0L45) on the TradingView platform. It provides financial data for the company, accessible through various features on TradingView. The page also outlines different products, community features, and business solutions …

ETFs Investing in Mirion Technologies, Inc. Class A Stocks

This article lists various ETFs that include Mirion Technologies, Inc. Class A stocks in their holdings. The ETFs are sorted by market value and provide financial data such as market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change …

Mirum Pharmaceuticals (MIRM) Projected to Announce Quarterly Earnings on Thursday

Scotts Miracle-Gro (NYSE:SMG) Updates FY 2026 Earnings Guidance

Miramar Resources Upgrades Joy Helen Drill Targets Following Successful Auger Campaign in Western Australia

Scotts Miracle Gro (SMG) Stock Looks Cheap On Cash Flow But Fair On Earnings

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Scotts Miracle-Gro stock has edged higher over the past year, yet its shares remain …

Mirum Pharmaceuticals (MIRM) Stock Looks Fully Valued On Current Sales Expectations

Mirum Pharmaceuticals (MIRM) stock is considered overvalued based on current sales expectations, despite a 7x return for investors over the past five years. The company trades at a P/S multiple of 12.3x compared to an industry average of 10.9x and a tailored fair multiple …

ETFs Investing in Scotts Miracle-Gro Company Class A Stocks

This article provides a list of Exchange Traded Funds (ETFs) that hold Scotts Miracle-Gro Company Class A stocks. The funds are sorted by market value and include details such as issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year NAV …

Is Scotts Miracle Gro (SMG) Overvalued As Sustainability Plans Meet A Valuation Gap?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Scotts Miracle-Gro (SMG) has put sustainability in focus with its 2026 Corporate Responsibility Report, outlining the GroForward 2030 plan on products, practices, and people, …

Miramar Resources Secures $438,703 in Junior Minerals Exploration Incentive Credits for FY25

12 Health Care Stocks Moving In Tuesday's Intraday Session

This article lists 12 health care stocks that experienced significant price movements during Tuesday's intraday trading session. It highlights several companies as top gainers, including China Pharma Holdings and Wellgistics Health, and also identifies key losers such as Zhengye Biotechnology and Lisata Therapeutics, providing …

ScottsMiracle-Gro Announces New Corporate Responsibility Strategy and Goals

The Scotts Miracle-Gro Company has released its 2026 Corporate Responsibility Report, outlining its new "GroForward 2030" strategy. This initiative focuses on responsibly produced solutions and aims to deliver positive impacts through goals centered on sustainable products, practices, and people. The strategy builds on the …

DEMIRE secures the UN as a tenant for around 10,000 m² in Bonn

DEMIRE Deutsche Mittelstand Real Estate AG DEMIRE secures the UN as a tenant for around 10,000 m² in Bonn Langen, 21 July 2026. DEMIRE Deutsche Mittelstand Real Estate AG (ISIN: DE000A0XFSF0) has signed a lease agreement with the Institute for Federal Real Estate (BImA) …

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 25.62% Potential Upside in the Biotech Arena

Mirum Pharmaceuticals, Inc. (MIRM) is highlighted as a compelling investment opportunity in the biotechnology sector, focusing on rare and orphan diseases. Despite a recent price dip, analysts project a 25.62% upside from its current stock price of $116.62, with an average target price of …

Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Down 17.2% - Here's Why

Earnings Preview: Mirion Technologies, Inc. (MIR) Q2 Earnings Expected to Decline

Mirion Technologies (MIR) Expected to Announce Quarterly Earnings on Tuesday

Mirrabooka Investments (ASX: MIR) Declares $0.095 Fully Franked Final Dividend Ahead of 30 July Ex-Date

ScottsMiracle-Gro Announces Timing of Third Quarter 2026 Financial Results and Webcast

The Scotts Miracle-Gro Company announced it will release its third-quarter financial results on Wednesday, July 29, 2026, before the U.S. financial markets open. The company will host a video presentation via webcast at 8:15 a.m. ET to discuss the results, followed by an audio …

Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

The EMA application is supported by data from the paediatric clinical programme for lebrikizumab, including the pivotal Phase III ADorable-1 study and the ADorable-2 long-term extension study. Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood – with …

Mirrabooka Investments (ASX:MIR) Advances as Investors Track Listed Investment Companies

Mirvac Group (ASX:MGR) Offers a 5.46% Yield – Could Its Property Pipeline Support Future Income?

Why (MIRM) Price Action Is Critical for Tactical Trading

This article analyzes Mirum Pharmaceuticals Inc. (NASDAQ: MIRM) for tactical trading, highlighting a mid-channel oscillation pattern and a strong risk-reward short setup. It details institutional trading strategies, including long, breakout, and short positions, alongside multi-timeframe signal analysis to guide traders on potential price movements.

Price to sales forward of Mirion Technologies, Inc. Class A – BMV:MIR

This article provides financial data for Mirion Technologies, Inc. Class A (BMV:MIR), specifically focusing on its forward price-to-sales ratio. It highlights that the market for this stock is currently closed with no trades. The content offers a snapshot of key financial metrics and disclaimers …

MIRM5806400 Bond Risk Profile

This article provides an overview of the MIRM5806400 bond issued by Mirum Pharmaceuticals, Inc. The bond has a 4.0% coupon and matures on May 1, 2029. It outlines key metrics for risk analysis, including security level, inflation protection, and issuer rating to help evaluate …

US604749AB7 Bond Profile — Key Metrics

This article provides key metrics for the Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029 bond (US604749AB7). It details the issuer, issue and maturity dates, outstanding amount, face value, and coupon rate. Mirum Pharmaceuticals, Inc. is described as a biopharmaceutical company focused on liver disease therapies.

Admiral Group (LSE:ADM) Stock Draws Fresh Price Target Split As Fair Value Edges Higher

Mirae Asset Securities Misses Entire SpaceX IPO Allocation Due to Email Timing Error

Mirrabooka Investments (ASX:MIR): A Classic ASX Income Stock for Dividend Seekers

Harvest Miracle Capital Malaysia 4th-Quarter 2026 Earnings Summary Table

Mirrabooka Investments Sets July Results Date and August Dividend Payment Schedule for Second Half 2026

Specialized Technology Stocks Q1 Results: Benchmarking Mirion (NYSE:MIR)

Admiral Shares Drop After RBC Downgrade on UK Motor Insurance Concerns (ADM)